PharmEste
Bresso
About PharmEste
PharmEste is a biopharmaceutical company, engages in the discovery and development of transient receptor potential (TRP) channel therapeutics for the treatment of neuropathic pain, overactive bladder, and other TRP-mediated diseases. It develops PHE377, a TRPV1 antagonist for the treatment of neuropathic pain.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Total funding: $17.1M
- Funding stage: Early Stage Venture
- Last round: Series B (Jun 2011)
- Website: pharmeste.com
Industries & Categories
Biopharma, Biotechnology, Therapeutics
Canonical: https://fsome.com/organization/pharmeste-1651421 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.